Inulin, particularly in combination with rifaximin, suppressed colon cancer metastasis by fostering beneficial BA-related bacteria (Eubacterium), reducing fecal DCA/LCA, and inhibiting the TGR5/NF-κB pathway (101). The gene discussed is GPBAR1; the disease is colonic neoplasm.